Contract Services
Samsung Biologics unlocks additional capacity for production at its newest Plant 4
Plant 4 commences GMP operations within just 23 months since groundbreaking, as planned Partial operations add fresh biomanufacturing capacity of 60,000...
October 12, 2022 | News
WuXi Biologics and Toregem BioPharma Sign MOU for Development of Anti-USAG-1 Antibody
Within the partnership, Toregem BioPharma will have access to WuXi Biologics' integrated CMC services in cell line development, cell banking and testing se...
October 12, 2022 | News
Vetter drives its sustainability campaign forward
Repeat participation in Baden Wuerttemberg’s Sustainability Days Greater inclusion of employees due to involvement in various initiatives Awards ...
October 11, 2022 | News
Australia's Paradigm Biopharmaceuticals reports positive early osteoarthritis drug trial results
Australian repurposing drug company Paradigm Biopharmaceuticals says positive clinical trial results for its osteoarthritis drug candidate indicate a poten...
October 07, 2022 | News
Merck Boosts Commercial Capacity in France as Part of New Millipore® CTDMO Services
New 2,700-square-meter facility expands production capacity for monoclonal antibodies (mAbs) and other recombinant proteins Clients benefit from differe...
October 05, 2022 | News
Samsung Biologics introduces new development platforms S-DUAL™ and DEVELOPICK™
Two distinctive platforms will streamline the antibody development process. With an advanced design and high binding affinity, S-DUAL™ ensures opt...
September 30, 2022 | News
Emmes (CRO) Acquires Clinical Edge
- Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical in...
September 30, 2022 | News
WuXi STA Opens First High Potency Oral Drug Product Manufacturing Facility
WuXi STA, a leading global Contract Research Development and Manufacturing Organization (CRDMO), today announced the opening of its first high potency (HP)...
September 27, 2022 | News
GMP cell CDMO I Peace, Inc. in collaboration with universities successfully converted human dermal fibroblasts into oligodendrocyte by direct reprogramming
This research was jointly conducted with Prof. Wernig at Sanford University and Prof. Rowitch at UCSF. The research was published in the online edition of ...
September 21, 2022 | News
Rapid growth puts Australian CRO Accelagen on the map for clinical research globally
Accelagen, one of Australia's leading Contract Research Organisations, has taken new 472sqM office space in Hawthorn East following two year...
September 20, 2022 | News
Redbud raises $10M in series A round as CRO focusing on science-driven clinical development
Redbud Medicine is a next-generation clinical CRO focusing on science-based clinical development services. The company offers full-service development from...
September 13, 2022 | News
WuXi STA Opens a New Sterile Lipid Nanoparticle Formulation Facility
WuXi STA, a subsidiary of WuXi AppTec, today announced the opening of a new sterile lipid nanoparticle (LNP) formulation development and manufacturing faci...
September 12, 2022 | News
Catalent Expands Singapore Clinical Supply Facility for Increased Temperature-Controlled Capabilities
The investment will increase the site’s footprint by nearly 20% to 31,000 square feet, and allow the installation of 35 new freezers for ultra-low ...
September 07, 2022 | News
APAC Attracts 50% of Global Clinical Trials According to New GlobalData Report
Download report here https://novotech-cro.com/whitepapers/evolution-clinical-trials-asia-pacific-region-compared-us-and-eu5In addition, the GlobalData...
September 05, 2022 | News
Most Read
- Taiwan Steps Into the Global Spotlight With a New Cancer Therapy
- The Role of Unique Device Identification (UDI) in Tracing Medical Device Safety
- The Importance of a Patient’s Mental Health During Clinical Trials
- Bridging the Vision Gap: Roche’s Ahmed Elhusseiny on Eye Health Priorities in Asia Pacific
- How Merck’s India-Based Navi Mumbai Centre is Reimagining Formulation Science for the Global Generics Market
- Advancing Cell & Gene Therapy in APJ: How Thermo Fisher Enables Breakthrough Innovation
- AstraZeneca’s Vision for Chronic Kidney Disease: Sylvia Varela on Transforming CKD Care in Asia
Bio Jobs
- Ravindra Rao Joins GOBI Technologies as Director of Life Sciences – APAC
- Amgen Announces $900 Million Expansion of Ohio Biomanufacturing Facility, Boosting Investment to Over $1.4 Billion
- Thermo Fisher Scientific Appoints Former CVS Health CEO Karen S. Lynch to Board of Directors
- Merck KGaA Reshapes Leadership for the Future with Key Executive Moves
- Aarian Health Appoints Thomas Keller as Business Director to Drive Innovation and Growth
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
News
Editor Picks
